Jean Gariépy
Chief Tech/Sci/R&D Officer at Ontario Cancer Institute
Profile
Jean Gariépy is the founder of Molecular Templates, Inc. which was founded in 2000.
He also held the title of Chief Scientific Officer at Molecular Templates, Inc. in 2009.
Dr. Gariépy's current jobs include being a Professor at the University of Toronto and a Senior Scientist at the Ontario Cancer Institute since 2009.
He previously worked as a Principal at the Princess Margaret Hospital Foundation.
Dr. Gariépy obtained a doctorate degree from the University of Alberta.
Jean Gariépy active positions
| Companies | Position | Start |
|---|---|---|
| University of Toronto | Corporate Officer/Principal | - |
| Ontario Cancer Institute | Chief Tech/Sci/R&D Officer | 2009-09-01 |
Former positions of Jean Gariépy
| Companies | Position | End |
|---|---|---|
| Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
| MOLECULAR TEMPLATES, INC. | Founder | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Founder | - |
Training of Jean Gariépy
| University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
| Princess Margaret Hospital Foundation | |
| Ontario Cancer Institute |
- Stock Market
- Insiders
- Jean Gariépy
